Skip to content

Contribution of Acupuncture on Pain Related to the Screening of Premature Retinopathy (ROP) by Digital Camera

Contribution of Acupuncture on Pain Related to the Screening of Premature Retinopathy (ROP) by Digital Camera

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03757871
Acronym
ELAROP
Enrollment
50
Registered
2018-11-29
Start date
2019-03-26
Completion date
2020-03-01
Last updated
2020-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laser Stimulation

Brief summary

Pain management in premature infants is essential because they are exposed to repeated minor painful procedures such as screening for premature retinopathy (ROP). Acupuncture has shown its analgesic effectiveness in many studies. Laser acupuncture is a simple, fast, side-effect-free method, but no study exists on the contribution of acupuncture in the management of pain caused by the examination of the fundus in addition to conventional therapies (suction, Glucose G30%, anaesthetic eye drops) which are not sufficiently effective. Hypothesis: Laser acupuncture is a medical device that would reduce the pain and discomfort of premature newborns when examining the fundus with a digital camera.

Detailed description

Randomized, single-centre, randomized, double-blind, randomized, controlled clinical trial in two parallel groups, acupuncture versus placebo as an add-on to the usual analgesic strategy (Glucose G 30%/suction and administration of a drop of anesthetic eye drops). The main objective is to evaluate the contribution of acupuncture versus placebo as an add-on to the G30% glucose solution 2 minutes before the examination associated with the instillation of a drop of oxybuprocaine administered 1 minute before the start of the examination on pain assessed at the first eye fundus (FO) by the score premature infant pain profile (PIPP) measured before the start of the examination (baseline) and on 30 seconds after the examination of both eyes.

Interventions

an acupuncture or placebo session will be performed 30 minutes before the fundus examination. This session will last 5 minutes.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
23 Weeks to 31 Weeks
Healthy volunteers
No

Inclusion criteria

* Premature from 23+0 to 30sa+6d regardless of birth weight with 1st FO for ROP screening; * Premature birth weights \< 1250g with a 1st FO for ROP screening; * Informed consent of the holder(s) of parental authority; * Child benefiting from a social security system

Exclusion criteria

* Analgesic or sedative drug treatment (benzodiazepines, morphine and related) within 48 hours of the examination. * Known chromosomal abnormality

Design outcomes

Primary

MeasureTime frameDescription
score at PIPP (premature infant pain profile) ≥ 1024 hoursMeasurement of pain or discomfort defined by a PIPP score ≥ 10

Secondary

MeasureTime frameDescription
pain and discomfort24 hoursAssess pain and discomfort (score FANS). The FANS score is a validated hetero-rating scale for assessing acute newborn pain when the face is difficult to analyse. On the 0 to 10 side, the absence of pain is defined by a score \< 3
heart rate variability24 hoursassessment of heart rate variability (NIPE score)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026